Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial
Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to study content or data were detected; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoChange DetectedOnly a page revision label was updated: v3.4.1 was added and v3.4.0 removed; there are no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded glossary toggle options (Show glossary, Hide glossary) and new QC/versioning metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.3%

- Check33 days agoChange DetectedAdded Revision: v3.3.4; Removed Revision: v3.3.3.SummaryDifference0.1%

- Check62 days agoChange DetectedDifference0.3%

- Check84 days agoChange DetectedThe page revision was updated from v3.2.0 to v3.3.2, with no substantive changes to the study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.